Case report

1‐deamino‐8‐D‐arginine vasopressin and cryoprecipitate in variant von Willebrand disease

Wahid Hanna, Joseph Slywka, Judith Dent, Zaverio M. Ruggeri, Theodore S. Zimmerman

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The effect of infusing DDAVP and cryoprecipitate either singly or in combination was studied in a patient with variant von Willebrand disease. Both DDAVP and cryoprecipitate caused only partial correction in the hemostatic defect when used as a single agent. A combination of DDAVP and cryoprecipitate induced a complete correction of the hemostatic defect as well as factor VIII related properties.

Original languageEnglish (US)
Pages (from-to)169-173
Number of pages5
JournalAmerican Journal of Hematology
Volume20
Issue number2
DOIs
StatePublished - Jan 1 1985
Externally publishedYes

Fingerprint

von Willebrand Diseases
Deamino Arginine Vasopressin
Vasopressins
Hemostatics
Factor VIII

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Case report : 1‐deamino‐8‐D‐arginine vasopressin and cryoprecipitate in variant von Willebrand disease. / Hanna, Wahid; Slywka, Joseph; Dent, Judith; Ruggeri, Zaverio M.; Zimmerman, Theodore S.

In: American Journal of Hematology, Vol. 20, No. 2, 01.01.1985, p. 169-173.

Research output: Contribution to journalArticle

Hanna, Wahid ; Slywka, Joseph ; Dent, Judith ; Ruggeri, Zaverio M. ; Zimmerman, Theodore S. / Case report : 1‐deamino‐8‐D‐arginine vasopressin and cryoprecipitate in variant von Willebrand disease. In: American Journal of Hematology. 1985 ; Vol. 20, No. 2. pp. 169-173.
@article{384ae87841cf44a0a3a256383d23df5a,
title = "Case report: 1‐deamino‐8‐D‐arginine vasopressin and cryoprecipitate in variant von Willebrand disease",
abstract = "The effect of infusing DDAVP and cryoprecipitate either singly or in combination was studied in a patient with variant von Willebrand disease. Both DDAVP and cryoprecipitate caused only partial correction in the hemostatic defect when used as a single agent. A combination of DDAVP and cryoprecipitate induced a complete correction of the hemostatic defect as well as factor VIII related properties.",
author = "Wahid Hanna and Joseph Slywka and Judith Dent and Ruggeri, {Zaverio M.} and Zimmerman, {Theodore S.}",
year = "1985",
month = "1",
day = "1",
doi = "10.1002/ajh.2830200210",
language = "English (US)",
volume = "20",
pages = "169--173",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Case report

T2 - 1‐deamino‐8‐D‐arginine vasopressin and cryoprecipitate in variant von Willebrand disease

AU - Hanna, Wahid

AU - Slywka, Joseph

AU - Dent, Judith

AU - Ruggeri, Zaverio M.

AU - Zimmerman, Theodore S.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - The effect of infusing DDAVP and cryoprecipitate either singly or in combination was studied in a patient with variant von Willebrand disease. Both DDAVP and cryoprecipitate caused only partial correction in the hemostatic defect when used as a single agent. A combination of DDAVP and cryoprecipitate induced a complete correction of the hemostatic defect as well as factor VIII related properties.

AB - The effect of infusing DDAVP and cryoprecipitate either singly or in combination was studied in a patient with variant von Willebrand disease. Both DDAVP and cryoprecipitate caused only partial correction in the hemostatic defect when used as a single agent. A combination of DDAVP and cryoprecipitate induced a complete correction of the hemostatic defect as well as factor VIII related properties.

UR - http://www.scopus.com/inward/record.url?scp=0021966955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021966955&partnerID=8YFLogxK

U2 - 10.1002/ajh.2830200210

DO - 10.1002/ajh.2830200210

M3 - Article

VL - 20

SP - 169

EP - 173

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 2

ER -